Clinical Trials in Arizona

Showing 15461-15480 of 16,770 trials

Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors

NCT00292864

The purpose of this study is to assess the safety and tolerability of one-hour infusions given once daily for 5 consecutive days in a 21-day treatment cycle; to define a recommended phase 2 dose; and to learn more about the clinical activity of SNS-032.

Tumors

Sunesis Pharmaceuticals25 participantsStarted Jan 2006

Scottsdale, Arizona, United States • Davis, California, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 331 miles

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

NCT00657904

The purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in subjects with histologically or cytologically confirmed non-metastatic adenocarcinoma of the prostate gland.

Non-metastatic Prostate Cancer

AstraZeneca3,618 participantsStarted Aug 1995

Birmingham, Alabama, United States • Mobile, Alabama, United States • Scottsdale, Arizona, United States +82 more locations

Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Find Trials by Condition in Arizona

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

A Study for Treatment of Pain in Patients With Diabetic Neuropathy.

Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

CP-675,206 In Patients With Advanced Melanoma

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak